Pod Insights The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch 20VC: Why Entrepreneurs Care Less About Firm Brand at Seed, How LPs Should Think About GP Commit & How The World of LPs and Fundraising Will Change Post COVID with Apurva Mehta, Managing Partner @ Summit Peak Investments About this episode Apurva Mehta is the Managing Partner @ Summit Peak Investments, investing in early stage venture capital funds and making direct co-investments. To date they have backed the likes of Raymond Tonsing, Lachy Groom and Josh Buckley to name a few on the fund side and then on the direct side, invested in Airtable, Virta Health and Sourcegraph. Prior to founding Summit Peak, Apurva spent 7 years as the Deputy Chief Investment Officer at Cook's Children's Hospital and before that spent 3 years as Director of Portfolio Investments at The Juilliard School. In Today’s Episode You Will Learn: 1.) How did Apurva make his way into the world of fund investing? How did that lead to his founding Summit Peak and also becoming a GP? 2.) How does Apurva think about how much importance to place on references when diligencing managers? What reference types mean a lot? Which mean less? Why does Apurva still believe early-stage is the most inefficient segment of the venture landscape? 3.) How does Apurva think about GP commits? Is it fair to have a required benchmark? How does Apurva advise founders on LP concentration limits? When is one LP too much of a fund? How does Apurva advise managers on selling a stake in the management company? 4.) As a fund of funds, how does Apurva approach fund portfolio construction today? How does this differ between the fund portfolio vs the direct portfolio? How does Apurva think about the compression of fundraising timelines both with GPs and Founders? Why does Apurva believe founders at the early-stage care less about firm brand today? 5.) How does Apurva feel about investing in managers he has not met in person? How does the GP/LP fundraising process need to change? How does COVID change the fundraising process for venture funds? How will LPs react to these changes? Items Mentioned In Today’s Show: Apurva’s Fave Book: Principles: Life and Work by Ray Dalio Apurva's Most Recent Investment: Sourcegraph As always you can follow Harry and The Twenty Minute VC on Twitter here! Likewise, you can follow Harry on Instagram here for mojito madness and all things 20VC.
Transcript Speaker names marked ? are inferred from speaking time and the show’s known hosts — they are not voice-verified.
0:00 Harry Stebbings? We are back and this is the 20 minute VC with me, Harry Stebbings. And if you'd like to suggest future guests or questions for future episodes, you can on Instagram at H Stebbings 1996 with two Bs. But to our episode today, and I always love interviewing LPs. And today is even more exciting as our guest is really a hybrid of an LP and a GP. And so with that, I'm thrilled to welcome Apurva Maitre, Managing Partner at Summit Peak Investments, investing in early-stage venture capital funds and making direct co-investments. To date, they've backed the likes of Raymond Tom Singh, Lachy Groom and Josh Buckley. Don't think you can get better managers in my perspective, but I might be slightly biased on those three. And then on the direct side, they also have investments in the likes of Airtable, Virta Health and Source Graph. Prior to founding Summit Peak, Apurva spent seven years as a Deputy Chief Investment Officer
0:45 Harry Stebbings? at Cook's Children's Hospital and before that spent three years as Director of Portfolio Investments at the Juilliard School. But before we move into the show today, digital hit a new gear in 2020 and companies need the tools that will allow them to flourish in our ever-changing world. That's where Amplitude comes in. Amplitude helps the top product and growth teams at companies like PayPal, Instacart, Peloton and Atlassian build product experiences that convert and retain customers. With their product intelligence platform, you and your team will better understand user behaviour, ship great product experiences faster and retain more customers. And they've become the gold standard in analytics for teams asking what is happening in their digital products? Why users are converting and what to build next?
1:26 Harry Stebbings? See for yourself how companies like Twitter, DoorDash and Cisco build for growth using Amplitude and visit amplitude.com/20vc and check this out. Discounted scholarship plans are available for qualifying startups. That's amplitude.com/20vc. And speaking of incredible products there, Harness is a truly modern digital wealth platform that leverages technology and best-in-class advisory firms to give you access to the best experienced human advice to maximise your finances. Harness helps tech employees and investors find the best solutions for their finances, from navigating stock sales to receiving partnership K1s. And they have the best advisors in the US and they know this because they diligence them through over 120 different attributes per advisor, meaning the process-
2:10 Harry Stebbings? That is both seamless and free and don't take my word for it. They've helped founders and early employees from companies like Stripe, Facebook and Plaid, and partners at VC firms like Coaster and General Catalyst. Go to harnesswealth.com/the20min VC to sign up. Plus 20 minute VC listeners can receive $100 off their first year fees when they sign up for an advisor on the Harness platform by entering the 20 minute VC all in letters and then 08 at the end. That's the 20 minute VC all in letters, 08. And finally, I have to take a moment to mention HelloSign, a great example of a company that found incredible success in building a product focused on user experience. HelloSign is the effortless e-signature solution used by millions to securely send and request legally valid digital signatures and agreements.
2:54 Harry Stebbings? And they raised a total of $16 million in funding and recently got acquired by Dropbox for an impressive $230 million. Check out hellosign.com/20vc to join the thousands of companies and founders who value fast, secure and simple e-signatures. But that's quite enough from me. So now I'm delighted to hand over to Apurva Mate, Managing Partner at Summit Peak Investments.
3:22 Speaker 01 You have now arrived at your destination.
3:25 Harry Stebbings? Apurva, I'm so happy to be doing this one. I've heard so many good things from Josh Buckley, from Lucky Guru Man, from the main man who introduced us, Ray Tonsing. So thank you so much for joining me, Stair Apurva.
3:34 Speaker 02 Harry, thank you so much. I'm a big fan and excited to be here.
3:37 Harry Stebbings? That is very, very kind of you and always a good start to inflate my ego. So thank you for that. But I do want to start with a little bit on you. And venture is a weird world to get into in the first place. And you have an even more unique position in the venture world, being both an LP and a GP at the same time. So tell me, how did you kind of make your way in and come to found Summit Peak most recently?
3:57 Speaker 02 So my partner, Patrick, and I founded Summit Peak in 2018. So we're two years into wearing a GP hat, but we've been LPs for a long time. As LPs, we spent 15 years as allocators, most recently as COCIOs for a children's hospital endowment in Fort Worth, Texas. And as part of that role, we were fortunate to build out a venture program, which helped build our name and network in the community. And since you mentioned Ray, Ray at Caffeinated, he was our first allocation in the venture space in 2012 and has been instrumental over the years in helping us build our name, build our brand, opening doors and introducing everyone in his network to us.
4:36 Harry Stebbings? Can I interrupt there and just ask, Ray, today, I said to you before, he's one of those investors where I will follow him blindly into any deal and I think he's truly special. That's quite obvious today when you look at his portfolio and I'm not alone in thinking that. When you backed him in 2012, he didn't have the portfolio that he has today and the brand that he has today. Can I ask, what did you see in him then?
4:57 Speaker 02 We were new to venture then and as we were new to the space, we were trying to understand the early stage part, segment of venture capital. Ray came to Fort Worth and maybe as a sort of the quintessential venture GP, he was in jeans and a T-shirt and sneakers and it was different. It was different than every other asset class that we were investing in. We had a meeting, we went through his angel portfolio, which was called Orange Wall, and he was putting together his first fund. The benefit of when we were coming into his first fund was 50% of it was invested. And at the time, it was, let's take a chance. It was a small allocation for us as part of a big portfolio. And what
5:39 Speaker 02 we saw in him was hustle. He had the hustle to want to help us build our name. He had the hustle to get himself into deals. And when we did reference checking, that's what proved a lot of that out, which was his hustle was going to get him into deals. And he had a phenomenal network. And at the time, it was, let's take a shot on this. If we're wrong, it is not meaningful to the portfolio. If we're right, we get to go build a venture portfolio. Look, it was not obvious then for sure, but it was the same way people took a chance on us a couple of years ago. We were taking a chance on Ray and it's paid off in spades.
6:13 Harry Stebbings? That's awesome to hear. I do have one more question before you properly dive into the schedule. And I'm sorry for going off schedule so soon. You mentioned kind of referencing there and I'm constantly umming and ahhing between how important it should be to a process. So I guess my question is, how do you place the importance of references? And how do you determine between kind of accepting versus rejecting that data point?
6:34 Speaker 02 You take it with a grain of salt, especially when a GP is providing references. We do the same in our business. We provide references to people. In addition to that, we use every other means possible within our network to reference beyond what somebody is giving us on a piece of paper. And so after you've taken that with a grain of salt, we put a lot of weight into it. I care a little bit less about when somebody's leaving a firm and what that firm is going to say. In early-stage venture, the most important piece is references from founders. And, you know, I would say in any new fund, we are doing anywhere between thirty to fifty reference calls with portfolio company founders. In some cases, we will do that with cold outreach.
7:17 Speaker 02 We know a portfolio. We might know what legacy investments look like. And we use this little used tool called LinkedIn and connect to founders. And I don't know, people seem to be openly willing to chat about their experience. And we hold a lot of weight on that. And in venture, again, it means less about what former colleagues and things like that say to us. But it really means a lot when a founder gives a reference of why a GP, why a VC is value add and why they would take their capital over and over again. And so it is one of the key areas for us in doing work on a GP.
7:50 Harry Stebbings? And this, I totally agree with you, especially on the kind of centrality of founder references. I do want to touch on, you mentioned the early-stage space there with Ray and we touched on Josh and Lachy. You've bet a lot of your career bluntly on the early stage for a long time. So I guess, really, how has it changed and evolved over the last eight years? And why have you been so bullish on it since then?
8:08 Speaker 02 So look, when we started this eight years ago, institutional allocators were generally down on venture as an asset class. If you look back to 2012, there was an overhang of illiquidity in venture post the global financial crisis. And add to that, the legacy brand name firms in Silicon Valley were hard to access. Generically, most allocators would say, if you can't access the brand name firms, don't bother building a venture portfolio. And so, call it contrarian or call it stubborn, my partner Patrick and I, we decided to challenge that view and decided to, you know, to try and build a venture portfolio in this new way, focusing on early-stage investing. We felt that it was the most inefficient segment of the market.
8:49 Speaker 02 And we decided, look, let's back micro VCs and early-stage funds centered around startup ecosystems. As far as the evolution, the simplest way to put it is the space has exploded. If you look back to 2012, I think by all accounts, there were probably 100 micro VCs in the market. And you fast forward to today and that number is over 1,000. And so, look, we're still bullish on the space. I think the fact that there are even more GPs today makes it even more inefficient. Even though there's tons of capital, it's still, I think, the most inefficient segment of venture capital. But we believe it is the best way to play into tech innovation. You are at the earliest stages, which means that you're getting into a company at the ground up. And the funds that we invest in have significant ownership.
9:32 Speaker 02 So we think that the ability to generate venture returns, quote unquote, you have the greatest chance at the early stage.
9:38 Harry Stebbings? I mean, you are preaching to the choir here, my friend, so I'm pleased to hear that. I do have to ask, so speaking of Ray Lockett and Josh, Nikhil, who previously was at Shasta, wrote about the rise of solo capitalists recently. I'm really interested to hear your thoughts. I'm actually very bullish on this as a movement and kind of a sustainable, ongoing theme of the ecosystem. How do you feel and think about the rise of the solo capitalist? And is this the tip of the iceberg? Or is this kind of the movement in itself and they are just the 1%?
10:04 Speaker 02 Look, we've been a believer in the space for quite some time and we're not just believers in the solo capitalist per se, or the, you know, as Nico put it, the rise of the solo capitalist. We think in the micro VC space, there are platforms that make sense as well. I think entrepreneurs, at least from our understanding and when, as I mentioned earlier on reference calls, entrepreneurs care less and less at the seed stage about brand. The legacy firms, they've been around for a long time and their capital is certainly valuable, but there is a stage where that matters. But at the seed stage, you want to know that you're sitting across the table from the decision maker, the person that is going to roll up their sleeves and help this business out in a pandemic
10:47 Speaker 02 or whatever the next crisis that we hit. And if we haven't already, we're moving more and more towards this idea that at the seed stage, pre-seed, seed and even up to the series A, you have these GPs, solo capitalists that are that. They are entrepreneurs turned investors that they know what you've been through. They are sitting across the table and saying, look, I can help you build this. And it's not to say that brand name firms can't do that, but there's more bureaucracy and there's more red tape for a multi-stage firm, for instance, to be able to make a decision as quick as a solo GP.
11:21 Harry Stebbings? No, absolutely true and I totally agree with you in terms of the potential kind of politics around decision making and how that can change the making process. I do want to touch on Summit Peak as well, because it's a very interesting fund structure in terms of, it's a fund of funds and it's obviously there's a direct caution. And I'm really interested because I speak to a lot of managers, obviously, on the VC side directly. And so when we think about, you know, raising Summit Peak as a fund of funds, how was the fundraising process for you?
11:45 Speaker 02 In three words, an emotional roller coaster. Look, we are fortunate to have an amazing group of LPs. We raised Fund One from 2018 to 2019 and we raised eighty four million dollars. It was nothing that we had expected, meaning I don't know if we had expectations. Our expectations were probably, you know, we've been doing this for a decade. We have a track record, we have a portfolio of GPs that you can see. This should be easy and we quickly realized how difficult. is to raise capital. That being said, for a first time fund and putting up an eighty four million dollar fund, we're extremely proud of the amount of capital we raised, we sort of slogged it through. And we also had GPs that were just great partners along the way and supportive through that process.
12:30 Harry Stebbings? I mean, that's fantastic, Taryn. You know, obviously, I had so many great things from Ray, which is lovely ahead of time. I do want to ask, if you're like reflective on the process, like there are a lot of things that when I look back on our fundraise, I would do differently and do again. When you think about what you did well that you'd do again, and what you don't think you did well and you'd change, what are those things that you'd do differently and those things that you keep doing the same?
12:51 Speaker 02 So on what we would do differently, a lot of our LPs know this story, but little known to other people, we committed the entire fund before we had even lined up an anchor investor. So we had nearly eighty million of company investments as well as fund investments by summer of two thousand and eighteen, right when we launched. And the reason for that was all of the GPs we wanted in this portfolio were raising capital. And we wanted to make sure that we could secure our LP advisory board seat and secure our allocation to, I would call now, hard to access funds. And so we had an eighty million dollar overhang of capital commitments and yet to raise any money. And, you know, a few months later.
13:32 Harry Stebbings? One sleepless night. I'm sorry, I would be shitting myself.
13:36 Speaker 02 So it was a year and a half of sleepless nights and this constant chasing your tails to raise capital. So that's one thing that I would say or give advice to not do again. We made it through, we raised capital and raised enough capital to meet our commitments. Like I said, we had supportive GPs that said, hey, we know you don't have money and we're okay if you commit to our fund, we know you're good for it. And that is, we couldn't have done it without them. You know, if you miss that capital call, it's okay, you can catch up. Or we won't call capital from you for six months and you'll be okay. But, that being said, I would never do that again. So that is the never do again. You know, as far as what went well, we tapped into our network. When you look at our Fund One and our Fund Two, a hundred percent or nearly a hundred percent of our capital
14:20 Speaker 02 came from people we've known for the past decade. And being an LP for so. You build an LP network and the people that came into our fund, they know us. So there's trust, respect and relationship. And then there's the investing side and they know how we invest. And so it's something that we were able to tap into for our fund. And we should tap into it more. I mean, frankly, we did a poor job of not really reaching our entire network. I mean, look, we're early in it, so that's why we have fund two and now a fund behind us. But it's something that I would say gave us a lot of success in raising capital, which was our network.
14:56 Harry Stebbings? No, I totally agree in terms of that network driven element. Can I ask, in terms of kind of strategies, obviously we spoke about the fundraise there and investors back you often because of the strategy as well as the people behind it. Now with Summit Peak, you had this very lovely opportunity to have a blank canvas and create what you wanted. When it came to portfolio construction, I'm just really interested from a fund of funds perspective of purpose. How do you approach portfolio construction? And bluntly, in terms of diversification, is it the same levels of diversification and how do you think about that?
15:25 Speaker 02 So look, our portfolio today mirrors how we've been investing for the last decade or eight years in venture, which is even with a blank canvas, we have had this approach of having a more concentrated approach, which means that we think 12 to 15 GPs is sort of the optimal number of GPs or funds to back as well as anywhere from 20 to 30 underlying direct or co-investment. So direct investments into companies or co-investments. If you dig in a little bit further on portfolio construction, we allocate 60% of our capital to early stage GPs. And these are people that we've now been backing since 2012. And they are now on their second, third, fourth or fifth vintage, you know, of their own life cycle.
16:10 Speaker 02 So 60% of the portfolio is for that. 10% is reserved for new GPs. So in our Fund One, we backed four new GPs. In our Fund Two, we have backed one new GP. And new GP just, it means either they're new to us, they could be on their Fund One, or they could be on their Fund Five, but they're just new to us. So we reserve that portion of our capital for those new GPs. And then 30% of our capital is reserved for. Co-investments as a lot of these micro VCs and early-stage funds, they ultimately will run out of pro-rata capital for later-stage rounds. So we like coming into a company at that inflection point of growth, and that could be as early as a Series A, as late as a Series C.
16:52 Speaker 02 So we reserve thirty percent of our capital for that co-investment piece of our portfolio.
16:57 Harry Stebbings? Totally get you. And I'm sorry for this, but I really have this opportunity with LP on the show. So I'm just going to pop you with questions that I'm too intrigued by. And it's that the first one is a lot of GPs come to me and say, hey, this LP wants to invest and it's actually thirty-five percent of like the total fund size. How do you advise managers on LP concentration and the LP concentration limits that you'd advise on?
17:18 Speaker 02 I don't have a strong feeling. I, look, it is, especially in this environment, it's tough because you have seen a lot of endowment and foundation groups, which could represent significant concentration of a portfolio or of a fund. Right now, they're retrenching and they're retrenching because this environment, they don't know if schools are going to open up in the fall or if you're a healthcare institution, you've been hit by COVID in various ways. And endowments and foundations, similar to maybe the global financial crisis, are focused on liquidity in tough times. And so if they're going to represent either as a whole, a large part of your capital base or individually a large part of your capital base,
18:01 Speaker 02 I would agree that it's tough while it's attractive to have that much capital from one LP. When it comes time to fundraise again, the fact that that could create a hole would be, I think, difficult. On our end, this is our business and this is all we're doing. We don't mind being severely concentrated and as so long as our funds continue to say what they're going to do, we're going to continue to be there. I think the very best way one of our GPs put it, an LP was doing a reference on us for our Fund One, and they asked one of our GPs, why would you take Summit Peak Capital over an endowment foundation? What makes them different? And the GP answered, he said, look, they staked their career on this. They left what they did to build Summit Peak.
18:44 Speaker 02 Not going anywhere. You know, if I perform, they will be in my fund vintage after vintage. Whereas an endowment foundation, there's turnover in investment offices every five years. And that's a less sure place that I'm going to get capital.
18:58 Harry Stebbings? That's really interesting, actually, though, because it's ironic. It's actually contrary to what a lot of people say, which is your endowments and your foundations are there for the really long term. But fund of funds have to go out and raise vehicles and they have these captive funds which one maybe can't rely on as much. So it's actually, you're suggesting a flip and actually because of the alignment of monetary incentives. If fund of funds perform because of their underlying portfolio, you've got them again.
19:21 Speaker 02 That's our belief. I mean, we'll see. But look, there are exceptions to the rule and we have endowment foundations as part of our own LP base. And so I certainly believe that they are good LPs. But we are seeing the shift more and more in these solo GPs and micro VCs. They are taking more and more capital from fund of funds that have a steady capital base. And I think it's also the speed of decision making. The process can be much quicker. And there's, again, no different than why an entrepreneur wants capital from a quote unquote solo capitalist and the speed of decision making to invest and be able to be a helpful GP. A VC GP, I think, likes the capital from a fund of funds because of that same exact concept.
20:05 Speaker 02 Which is the speed of our decision making, there is no red tape. There are two of us making a decision. And we can move quick on diligence and reference calls and there's no investment committees. So I think it's a similar concept.
20:16 Harry Stebbings? I totally agree with you there in terms of the speed of decision making. Another question for me is a lot of like earlier or sometimes first time fund managers in the fundraising process and they say, hey, this LP, you know, wants to put in 20 million and be a big anchor. But they want to buy part of the management company and they really want a piece of flash for it. How do you advise managers on selling part of the management company? And that hurdle, which a lot of first time fund managers especially do face.
20:42 Speaker 02 I wouldn't do it. It's, I think you slog it out. It's expensive capital. Ultimately, as a GP, now we're in that seat. It's okay to give an anchor investor a break on fees. That's one thing. But giving up a piece of your management company, it makes that LP very expensive. And ultimately, I think as a GP, you come to resent that. You're already working so hard. Everything you're doing are for the back-ended economics and then to give a portion of that up would be difficult. So whether you're a solo GP, we know it's tough, having gone through fundraising and going through it again. It's that emotional roller coaster. There are LPs out there. There's family offices, there's fund of funds. It's just giving up a piece of the management company is just, it's hard to reverse decision.
21:26 Harry Stebbings? Yeah, Lewis and I agree with you totally. You mentioned the fees and the carry element there. It's often one that emerging managers ask me about, which is which one, bluntly, and I shouldn't say this to an LP. But they kind of go, which one can I jack up without LPs being too pissed at me? Can I jack up the fees fully to two and a half? Or can I jack up carry with kickers to thirty percent post three or four X or whatever we decide that hurdle to be? How do you feel about sensitivities around the two? I've found that actually there's more sensitivity around carry than there is fees from the LP side. How do you feel about it?
21:59 Speaker 02 At the end of the day, because we're a fund of funds, we have to be sensitive to fees. But that being said, when it comes to running a business, we generally are not sensitive to the management fee. I mean, so you're right on that. We're not sensitive to it because we understand that whether you're a new fifty million GP or a new twenty five million, the management fees are going to run the business. And a lot of these GPs, whether it's a first-time fund or not, they haven't necessarily made a ton of money. And unless you're independently wealthy, the two and a half percent is literally just going to pay for the office and pay for a nominal salary in what's most likely an expensive city. So we rarely push back on management fee.
22:41 Speaker 02 I mean, ultimately, that two and a half percent, it tears down so that you do get to an average of two percent. And I agree with you. I think LPs generally are okay with that. On the carry side, I would also agree LPs do push back on carry hurdles. My view is, is look, if we're making that return over where that hurdle is, I'm okay giving up that further upside. We're a believer in if a GP performs and if they're hitting that, then they should get compensated and everybody is going to walk away being happy if they're earning those net returns. So generally speaking, we're not pushing back on an overall fund on the carry terms. Again, the management fee is not something that a GP is getting rich off of.
23:25 Speaker 02 It's the carry that they're working hard towards and if they're gonna hit those return hurdles, well then they should get compensated for it.
23:31 Harry Stebbings? Totally agree with you and I look forward to your email being completely fucked after this interview.
23:38 Harry Stebbings? I gotta ask another one and I'm sorry, it's totally away from schedule, but I love conversations like this. On the GP commit side, how do you feel about GP commits? Cause when I was raising, there was a lot of people who were like, oh, we like managers have 3%. And I'm like, that would be three million pounds and I'm 22. Where do you think I came from? How do you feel about GP commits, making them proportional and what you would like and expect to see?
23:59 Speaker 02 Yeah, this is another interesting question, having just flipped the switch from LP to GP. So as an LP, we did the same. I mean, we said, wow, you have to have 2% at a minimum. And I just went and said to you that management fees are keeping the lights on and GPs aren't getting rich off of them and they generally haven't made a ton of money yet. One of our GPs, anecdotally, he had spun out of a family office. He was raising his first fund, it was a $25 million fund and we were the anchor investor. And we pounded the table as an LP, you gotta have 2%. You have to contribute a certain amount in cash as opposed to management fee waiver. And we didn't realize what that hardship necessarily entailed.
24:42 Speaker 02 I mean, he had to sell an apartment to generate the cash to make his GP commit as high. And he didn't have the liquid net worth to do it. He did it and I have a lot of respect for him for doing so. And fast forward, and when we created our business, it was the same conversation. You have to have a 2% GP commit on a hundred. Million dollar fund, that's two million dollars. I'm not twenty two, but Patrick and I spent our careers in the endowment foundation space, which frankly is different and does not pay millions of dollars a year. And so putting two million dollars as a GP commit is a lot of money. It is when we say we have skin in the game, every ounce of our net worth is invested into our fund one and then whatever's remaining into our fund two.
25:26 Speaker 02 So I have empathy for GPs on that GP commit. We do love seeing a higher number, eat your own cooking. Some of our GPs have ten percent, fifteen percent, twenty percent. They're fortunate to be in that position. But we do have empathy with GPs that are in the position that they can just scrape together the two and we have a lot of respect for that as well.
25:46 Harry Stebbings? Yeah, no, listen, I do totally agree. I think it becomes really challenging though, when it comes to the next fund and you're asked to pony up again. My question to you is, you know, we've seen the speed of fund deployment to be massively, massively kind of curtailed with some big brands spending their funds in twelve months even so. But the majority are kind of eighteen to twenty four, but still much smaller kind of timeframe than the thirty six months than was normally expected. How do you feel about the reduced timeline of deployment? And how do you advise your managers today in terms of deployment timelines?
26:16 Speaker 02 We are in the business of backing GPs and the pace of their deployment should not be something I should be giving them advice on. When we back them, we understand how quickly they're going to deploy capital and there's a rough schedule of what that pacing should look like. I think where it gets tricky is when GPs keep coming back and you haven't necessarily proven anything out. You spend a fund one and you come back with fund two within eighteen months and that's okay. I think the decision to invest in a GP is generally a two or three fund decision. And there are certain metrics that you can track that we think of internally when there's very little distributions because it's venture and it's early.
26:56 Speaker 02 So it's not just purely reliant on distributions. You obviously should see some marks in the portfolio. So I think when you go in, you have to go in with eyes wide open, knowing how quickly a GP is going to deploy. We're cycle agnostic, so we Want to be investing in venture irrespective of what's going on in the market. And our GPs are generally that way, too. They are investing year in, year out, and they always want to have capital to be backing the very best entrepreneurs. And we want to make sure they have that capital. So I think you can mitigate it by understanding that pacing and sizing accordingly. So in our own fund, we know that some managers are going to come back every year with a new fund or every eighteen months.
27:39 Speaker 02 And so instead of a normal sized allocation, you cut it in half so that we can have the capital to go back fund after fund after fund. And so there are ways to get around it. The last thing we do is give advice on you're deploying too capital too fast. The only thing we can do is internally track metrics and see are they continuing to invest the way that they said they were going to invest? And track progress in other ways beyond TVPI and DPI.
28:04 Harry Stebbings? Can I ask one metric that I often hear that I just don't understand and I'd love your help on is when people say, ah, you know, how many of their companies got done by tier ones to the next round? And I go, well, actually, if they have reasonably sized funds and they're very close to their portfolio companies, it would make a lot more sense to proactively allocate capital into those companies, do internal rounds and build ownership. Now, it doesn't get the LP approval on the metric side because Sequoia haven't done it, but they've just gained ownership and now are sitting at twenty-two percent in a really high performing company. So I think it's kind of a bit of a bullshit metric. How do you think about that? And am I wrong on being flippant?
28:39 Speaker 02 I don't know. I don't know because when you look at the GP presentations, they say our companies are backed by the very best funds at later rounds. I mean, we see that in GP presentations all the time. Ultimately, as long as the company is doing well, it's well funded and they have the right people at the table. That's all that matters. And if you were to ask some of our GPs, they could care less what the name of the firm is at the next round. It's again, the value add of that fund. Are they going to help this company grow from a fifty million dollar revenue business to a hundred million dollar revenue business? And that's what's most important. And we would agree there. Again, we want to see the companies do as well as possible. And so whatever that warrants in terms
29:22 Speaker 02 The investor and who that investor is, that's the most meaningful piece. Look, I would be bullshitting you to say that it's not important to us. Those brand names do matter, whether that's Benchmark Capital, Andreessen Horowitz, Sequoia Capital. They are great funds and they're great investors at various stages. And you wanna see companies being well-funded by some of them. And so we think about those as metrics. Again, maybe less at the earlier stages, but when you get into mid to later stages, absolutely. I think it is something LPs like to see. It is something that we certainly are keen to understand. And if they're not in the company, that's okay too. That means it's maybe misunderstood. It's misunderstood by some of the bigger brands and that just means it's undervalued potentially.
30:06 Speaker 02 So I know that was a almost a non-response. I mean, we care about it. We care ultimately how well the company does. And as long as it's financially stable and has the right backers, that's the most important. But it is nice to see and we have one of those slides in our presentation too. We invest alongside of the very best.
30:24 Harry Stebbings? Last question that I'm really interested by is you're based in Texas and you have this incredible tight network in the valley. Bluntly, how do you build the tight relationships of trust from that distance? And then two, how do you think the world of like LP investing changes in the COVID world?
30:40 Speaker 02 Yeah, so pre-COVID, location didn't matter. Meaning, we started this in 2012. We dedicated just the resources, myself and Patrick. We spent all of our bandwidth in Silicon Valley. We became members of the battery. We did all of our meetings there and we built our network in Silicon Valley. To the point where now location doesn't matter. You being in the UK, I'm sure you can attest to this. It's about who you know, not where you're located and what kind of relationship you have with those folks. So we spent the time, I would say, required then to build our network in the valley. Which means that today, everybody is a phone call, text or WhatsApp away.
31:20 Speaker 02 And pre-COVID, what we did was we would be in Silicon Valley at least two weeks of every month. And we built a community around what we do. So, you know, in addition to just being an LP, we would. Organize community events and we would have founder dinners and GP dinners where we would collaborate and have all of our GPs around the table and ask them to bring a founder. And this was pre having a fund. We were building our name and our brand as, look, let's bring the venture community together. Now, I know funds do this all the time and bring founders together, but we were doing it as an LP and saying, let's bring funds together and they can share ideas. And so, fast forward, post-COVID, we still do that. We do GP Zoom happy hours, Fund of Fund Zoom happy hours,
32:05 Speaker 02 various things to kind of continue to bring that community together. So in a COVID world, being located in Texas is no different than pre-COVID. And we still have that strength of our network to help us to navigate. As far as being an LP, again, I don't think it matters all that much to us. I mean, we like strong relationships with our GPs. Josh Buckley is an example of an investment that we made in a COVID world where we weren't able to get on a plane to meet somebody and have a meal with them and just spend time getting to know them. And we have to do everything via Zoom and reference calls. We are okay with that and we've done that pre-COVID.
32:45 Speaker 02 I think it's going to be tough for LPs. It's going to be strength of relationship and network that ends up bringing LPs to the table. But I also do believe LPs are going to have to shift the way they think. You know, if people aren't getting on planes for the next six months at a minimum to travel, you're gonna have to innovate how you do diligence, which means that you're gonna have to, you know, if you want to continue to allocate capital, it's gonna mean doing it via Zoom, I suppose.
33:10 Harry Stebbings? No, listen, I'm looking forward to the innovation. I think it's thoroughly needed, but I do also actually miss the in-person hugely, especially on the kind of the building relationship side. So I'm with you there and fingers crossed we won't lose it entirely. I do want to move into my favorite though, Purb, which is the quickfire. So I'm saying a short statement and then you hit me with your immediate thoughts. Does that sound okay?
33:29 Speaker 02 That sounds great.
33:29 Harry Stebbings? Okay, so what's the favorite book and why?
33:32 Speaker 02 So recently, probably a few years ago, Ray Dalio's Principles. It's a great book to dig into and develop decision-making skills, which we use daily, whether investing or Personally, it's just phenomenal from that perspective.
33:44 Harry Stebbings? What's the hardest element of your role with Summit Peak today?
33:47 Speaker 02 Juggling, wearing multiple hats, which is being an investor as an LP, running a business, fundraising, just all of that in one.
33:55 Harry Stebbings? Yeah, I think people forget the difference between being an investor and being a fund manager, and it's fundamentally very different, I find. So yeah, totally agree there. Tell me, the biggest mistakes you see first time fund managers make when raising?
34:06 Speaker 02 Clearly articulating their edge and differentiation. We see hundreds of pitch decks and we walk away from some calls and walk away not having learned anything. You know, why are they different? Why are founders gonna back them? That is the key thing that first time fund managers need to, I think, in a deck, try to articulate.
34:24 Harry Stebbings? Yeah, no, I totally agree. I think kind of the why us and also the why now, I often find they don't kind of stage it in the thematic transitions that venture has. So like if you have sort of capitalists now, do you know what I mean?
34:35 Speaker 02 Yep.
34:35 Harry Stebbings? Totally with you there. Tell me, this is ironic coming from me being in London and you being in Texas. What's your favorite restaurant in London and why?
34:42 Speaker 02 Anything Indian, literally, I mean, Indian by background, but London is one of my favorite cities. And I could eat my way through London in any Indian cuisine. So whether that's Dishoom, Jim Kana, the list goes on, but I love all of the Indian restaurants in London.
34:58 Harry Stebbings? I love it too, and Dishoom is one of my favorites. Tell me, what would you most like to change about the world of tech and maybe venture more specific?
35:05 Speaker 02 The biggest thing I would say is transparency. From an LP perspective, it's an enigma. People don't understand the asset class. GPs, I would say, are coming around from a transparency perspective. And as we build Summit Peak, we're trying to build a platform that is educational. So we educate our LPs and we're transparent. They know how we're deploying capital. They know what these companies are doing. And I would love to see more of that. We have great relationships with our GPs, so I don't feel like I'm ever in the dark. But that being said, I think as an industry, it is this black hole of how do people generate returns and what are they doing with their capital?
35:45 Harry Stebbings? Totally. Tell me, what's the most recent publicly announced investment and why did you say yes and get so excited?
35:51 Speaker 02 Most recent would have been in March of this year. We co-invested in a company called Sourcegraph, which was led by Kraft Ventures on participation by Goldcrest Capital and Redpoint Ventures. We've known the founder since the business started. It was an early investment of Goldcrest Capital. Had met the founder over the last four to five years and were thoroughly impressed with the team and product they've built. The opportunity came to us for the Series B, literally at the start of shelter in place in many places. And we're excited about what their vision was and how they were executing on enterprise sales. It's an enterprise sales business. We had gotten to know the business really well and we were able to step in, you know, at a time where people froze up on capital.
36:35 Harry Stebbings? Yeah, no, I'm totally with you. Pretty phenomenal business and I had many good things from the guys at Kraft. So that's fantastic here. But listen, I've wanted to do this for a while since hearing so many good things from Ray. So thank you so much for joining me today, Pervah, and I've so enjoyed it.
36:47 Speaker 02 Thank you so much, Harry.
36:50 Harry Stebbings? I have to say, really, I'm very excited for all Summit Pika doing for the ecosystem. An incredible partnership there with Patrick and with the Pervah. And so if you'd like to hear more from me, you can find me on Instagram at Hstabbings1996 with two Bs. There we have all things behind the scenes and you can suggest both guests and questions for future episodes. However, before we leave you today, digital hits a new gear in 2020 and companies need the tools that will allow them to flourish in our ever-changing world. That's where Amplitude comes in. Amplitude helps the top product and growth teams at companies like PayPal, Instacart, Peloton and Atlassian build product experiences that convert and retain customers. With their product intelligence platform, you and your team will better understand user behavior, ship great product experiences faster and retain more customers. And they've become the gold standard in analytics
37:36 Harry Stebbings? for teams asking what is happening in their digital products? Why users are converting and what to build next? See for yourself how companies like Twitter, DoorDash and Cisco build for growth using Amplitude. And visit amplitude.com/20vc and check this out. Discounted scholarship plans are available for qualifying startups. That's amplitude.com/20vc. And speaking of incredible products there, Harness is a truly modern digital Wealth platform that leverages technology and best-in-class advisory firms to give you access to the best experienced human advice to maximize your finances. Harness helps tech employees and investors find the best solutions for their finances, from navigating stock sales to receiving partnership K1s. And they have the best advisors in the US and they know this because they diligence them
38:21 Harry Stebbings? through over 120 different attributes per advisor, meaning the process is both seamless and free. And don't take my word for it, they've helped founders and early employees from companies like Stripe, Facebook and Plaid, and partners at VC firms like Coaster and General Catalyst. Go to harnesswealth.com/ the 20 minute VC to sign up. Plus 20 minute VC listeners can receive $100 off their first year fees when they sign up for an advisor on the Harness platform by entering the 20 minute VC all in letters and then 08 at the end. That's the 20 minute VC all in letters, 08. And finally, I have to take a moment to mention HelloSign, a great example of a company that found incredible success in building a product focused on user experience.
39:02 Harry Stebbings? HelloSign is the effortless e-signature solution used by millions to securely send and request legally valid digital signatures and agreements. And they raised a total of $16 million in funding and recently got acquired by Dropbox for an impressive $230 million. Check out hellosign.com/20vc to join the thousands of companies and founders who value fast, secure and simple e-signatures.
39:25 Speaker 01 As always, I so appreciate all your support and I can't wait to bring you an incredible Founder episode with House Party founder Ben Rubin on Friday.
Previous 20VC: Why Few Firms Are Doing True Early Stage Investing Today, Why Founders Should Spend Time with Analysts When Raising & The Rise of Pre-Empting Rounds and How To Know When To Engage vs Wait with Anna Khan, General Partner @ CRV Next 20VC: Biggest Lessons From Scaling Houseparty To Millions of Users, Why Today's Metrics Are Insufficient To Determine Product Success & What Breaks with Scale From Team To Product with Ben Rubin, Co-Founder @ /talk & Houseparty Page updated October 26, 2026 · transcript and summary are machine-generated